1. Home
  2. CCS vs VIR Comparison

CCS vs VIR Comparison

Compare CCS & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Communities Inc.

CCS

Century Communities Inc.

N/A

Current Price

$51.68

Market Cap

1.7B

ML Signal

N/A

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

N/A

Current Price

$9.33

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCS
VIR
Founded
2000
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
CCS
VIR
Price
$51.68
$9.33
Analyst Decision
Buy
Strong Buy
Analyst Count
5
7
Target Price
$64.80
$19.43
AVG Volume (30 Days)
253.8K
1.5M
Earning Date
04-22-2026
05-06-2026
Dividend Yield
2.31%
N/A
EPS Growth
N/A
17.49
EPS
0.84
N/A
Revenue
$4,117,816,000.00
$68,556,000.00
Revenue This Year
N/A
$270.22
Revenue Next Year
$10.84
N/A
P/E Ratio
$61.60
N/A
Revenue Growth
N/A
N/A
52 Week Low
$50.42
$4.16
52 Week High
$76.00
$11.66

Technical Indicators

Market Signals
Indicator
CCS
VIR
Relative Strength Index (RSI) 35.20 43.91
Support Level $51.57 $8.47
Resistance Level $66.29 $10.29
Average True Range (ATR) 1.87 0.41
MACD -0.39 -0.15
Stochastic Oscillator 7.12 12.85

Price Performance

Historical Comparison
CCS
VIR

About CCS Century Communities Inc.

Century Communities Inc is engaged in the development, design, construction, marketing and sale of single-family attached and detached homes. The company builds and sells homes under its Century Communities and Century Complete brands. Its reportable segments for homebuilding operations are: i) West (California and Washington) ii) Mountain (Arizona, Colorado, Nevada and Utah), iii) Texas, iv) Southeast (Florida, Georgia, North Carolina, South Carolina and Tennessee), v) Century Complete (Alabama, Arizona, Florida, Georgia, Indiana, Kentucky, Michigan, North Carolina, and South Carolina). The company's other reportable segments include: Financial Services and Century Living. The company derives the majority of its revenue from the sale of new homes in the Mountain segment.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Share on Social Networks: